Treating relapsed multiple myeloma outside of use of T-cell redirected therapies

Guiding transplant decisions in multiple myeloma with MRD

Revolutionising multiple myeloma treatment with CAR T-Cell therapies

WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India

Alternative livelihood training programme for rural women who are employed in the tobacco industry in India

Choosing the right Tyrosine Kinase Inhibitors (TKI) for CML Patients

Multiple Myeloma: evolving paradigm - Panel Discussion

Advancements in paediatric Acute lymphoblastic leukemia management

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies

Choosing 1st line TKI Wisely in patients with CML

Choosing the right patients for transplant